Published in Pediatr Nephrol on March 21, 2006
The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation. Eur J Clin Pharmacol (2011) 0.90
Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients. Eur J Clin Pharmacol (2012) 0.90
Pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients. Pediatr Nephrol (2009) 0.79
Therapeutic drug monitoring in pediatric renal transplantation. Pediatr Nephrol (2014) 0.78
Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol (2015) 0.76
Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients. Br J Clin Pharmacol (2014) 0.75
Evaluation of tacrolimus abbreviated area-under-the-curve monitoring in renal transplant patients who are potentially at risk for adverse events. Clin Transplant (2010) 0.75
A Markov chain model to evaluate the effect of CYP3A5 and ABCB1 polymorphisms on adverse events associated with tacrolimus in pediatric renal transplantation. AAPS J (2013) 0.75
Tacrolimus dose requirements in paediatric renal allograft recipients are characterized by a biphasic course determined by age and bone maturation. Br J Clin Pharmacol (2016) 0.75
Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients. Pharmaceutics (2010) 0.75
A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics (1976) 13.83
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Developmental pharmacology--drug disposition, action, and therapy in infants and children. N Engl J Med (2003) 7.51
Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet (1995) 1.96
Individualization of cyclosporine therapy using pharmacokinetic and pharmacodynamic parameters. Transplantation (1985) 1.83
Tacrolimus: a further update of its use in the management of organ transplantation. Drugs (2003) 1.72
Relationship of FK506 whole blood concentrations and efficacy and toxicity after liver and kidney transplantation. Transplantation (1996) 1.57
Mechanisms of clinically relevant drug interactions associated with tacrolimus. Clin Pharmacokinet (2002) 1.41
Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation. Nephrol Dial Transplant (2003) 1.34
Comparative clinical pharmacokinetics of tacrolimus in paediatric and adult patients. Clin Pharmacokinet (2001) 1.18
Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol (2001) 1.07
Effect of low- and high-fat meals on tacrolimus absorption following 5 mg single oral doses to healthy human subjects. J Clin Pharmacol (2001) 1.02
Low systemic exposure to tacrolimus correlates with acute rejection. Transplant Proc (1999) 0.99
Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients. Eur J Drug Metab Pharmacokinet (1999) 0.96
Cyclosporin pharmacokinetics in paediatric transplant recipients. Clin Pharmacokinet (1997) 0.95
Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose. J Clin Pharmacol (2001) 0.92
Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children. Pediatr Transplant (2002) 0.91
Increase in tacrolimus trough levels after steroid withdrawal. Transpl Int (2003) 0.88
Immunosuppressive therapy for paediatric transplant patients: pharmacokinetic considerations. Clin Pharmacokinet (2002) 0.83
Pharmacokinetically determined cyclosporine dosage in young children. Pediatr Nephrol (1991) 0.83
Pharmacokinetics of tacrolimus in pediatric renal transplant recipients. Transplant Proc (2001) 0.81
Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients. Transplant Proc (2001) 0.79
Pharmacokinetics of cyclosporine after renal transplant in children. J Clin Pharmacol (1996) 0.79
Comparison of ELISA method versus MEIA method for daily practice in the therapeutic monitoring of tacrolimus. Nephrol Dial Transplant (2001) 0.78
Pharmacokinetics of tacrolimus in paediatric renal transplant recipients. Transplant Proc (2002) 0.76
Quality assurance procedure for monitoring tacrolimus (FK506) concentrations in whole blood by IMx assay. Ther Drug Monit (1996) 0.75
One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient. Transpl Int (2005) 0.75
Errors in laboratory medicine. Clin Chem (2002) 4.87
Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial. BMJ (2007) 3.88
Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation (2005) 3.57
Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem (2007) 3.23
Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer (2006) 2.89
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. Cardiology (2010) 2.88
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology (2008) 2.63
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol (2006) 2.61
COQ2 nephropathy: a newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol (2007) 2.52
Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics (2008) 2.42
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. Int J Cardiol (2012) 2.28
Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med (2011) 2.01
How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J (2012) 2.00
Identifying risk in the use of tumor markers to improve patient safety. Clin Chem Lab Med (2016) 1.91
Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J (2010) 1.88
Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med (2006) 1.85
What's next in translational medicine? Clin Sci (Lond) (2007) 1.85
Rituximab in children with resistant idiopathic nephrotic syndrome. J Am Soc Nephrol (2012) 1.83
Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J (2005) 1.80
Influence of the CYP3A5 genotype on tacrolimus pharmacokinetics and pharmacodynamics in young kidney transplant recipients. Pediatr Transplant (2007) 1.75
Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol (2011) 1.67
Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy. Stroke (2010) 1.67
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine (2004) 1.65
Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci (2004) 1.65
Effects of sample transportation on commonly requested laboratory tests. Clin Chem Lab Med (2012) 1.64
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol (2005) 1.63
Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.62
Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int (2002) 1.61
Automated blood cell counts: state of the art. Am J Clin Pathol (2008) 1.59
Quantification of serum levels of pepsinogens and gastrin to assess eradication of Helicobacter pylori. Clin Gastroenterol Hepatol (2010) 1.58
Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci (2011) 1.56
Accreditation of medical laboratories in the European Union. Clin Chem Lab Med (2007) 1.55
Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 1.55
Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it. Clin Chem Lab Med (2015) 1.53
Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med (2013) 1.52
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chim Acta (2012) 1.51
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas (2006) 1.50
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Transfusion (2012) 1.50
Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med (2008) 1.50
Shop for quality or quantity? Volumes and costs in clinical laboratories. Clin Chem Lab Med (2013) 1.50
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med (2014) 1.49
Ultrasound, anthropometry and bioimpedance: a comparison in predicting fat deposition in non-alcoholic fatty liver disease. Eat Weight Disord (2014) 1.48
The syndrome of the "obsessive-compulsory scientist": a new mental disorder? Clin Chem Lab Med (2013) 1.47
Protein turnover, lipolysis, and endogenous hormonal secretion in critically ill children. Crit Care Med (2002) 1.47
Quality Indicators in Laboratory Medicine: from theory to practice. Preliminary data from the IFCC Working Group Project "Laboratory Errors and Patient Safety". Clin Chem Lab Med (2011) 1.44
Three-yr safety and efficacy of everolimus and low-dose cyclosporine in de novo pediatric kidney transplant patients. Pediatr Transplant (2014) 1.44
Anti-Helicobacter pylori antibodies in cervical mucus: a new cause of infertility. Eur J Obstet Gynecol Reprod Biol (2010) 1.43
Prevalence and Clinical Relevance of IgE Sensitization to Profilin in Childhood: A Multicenter Study. Int Arch Allergy Immunol (2015) 1.42
CCLM: evolving to meet the needs of today's laboratory professionals and scientists. Clin Chem Lab Med (2008) 1.42
Effect of maternal smoking on breast milk interleukin-1alpha, beta-endorphin, and leptin concentrations and leptin concentrations. Environ Health Perspect (2005) 1.42
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J (2011) 1.42
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res (2011) 1.41
Oxidative stress and post-transplant hypertension in pediatric kidney-transplanted patients. J Pediatr (2006) 1.40
Is laboratory medicine a dying profession? Blessed are those who have not seen and yet have believed. Clin Biochem (2010) 1.40
Reduction of unsuitable specimens: a more radical and comprehensive approach is needed. Clin Chim Acta (2010) 1.39
Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med (2015) 1.39
What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease? Liver Int (2009) 1.39
The effect of donor/recipient body surface area ratio on outcomes in pediatric kidney transplantation. Pediatr Transplant (2008) 1.39
Allergy diagnostics and the allergist's loneliness. Eur Ann Allergy Clin Immunol (2007) 1.38
Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol (2003) 1.33
Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J Clin Endocrinol Metab (2010) 1.33
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int (2013) 1.33
Quality specifications in EQA schemes: from theory to practice. Clin Chim Acta (2004) 1.29
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol (2008) 1.27
Pathogenesis of Helicobacter pylori infection. Helicobacter (2010) 1.26
Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. Clin Chem Lab Med (2009) 1.25
Evaluation of effectiveness of a computerized notification system for reporting critical values. Am J Clin Pathol (2009) 1.23
Increased serum resistin in nonalcoholic fatty liver disease is related to liver disease severity and not to insulin resistance. J Clin Endocrinol Metab (2006) 1.23
Biological variation and reference change values: an essential piece of the puzzle of laboratory testing. Clin Chem Lab Med (2012) 1.22
Polyomavirus BK-specific immunity after kidney transplantation. Transplantation (2004) 1.22
Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide. Pancreas (2002) 1.22
The IFCC Working Group on laboratory errors and patient safety. Clin Chim Acta (2009) 1.21
Value of imaging studies after a first febrile urinary tract infection in young children: data from Italian renal infection study 1. Pediatrics (2009) 1.21
Multicenter evaluation of the hemolysis index in automated clinical chemistry systems. Clin Chem Lab Med (2009) 1.20
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis. Clin Chem (2002) 1.20
Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department. Pediatr Infect Dis J (2007) 1.19
CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer (2007) 1.18
Human mesenchymal stem cells inhibit antibody production induced in vitro by allostimulation. Nephrol Dial Transplant (2007) 1.17
Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer. BMC Cancer (2008) 1.16
Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum Mutat (2012) 1.15
VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study. Pharmacogenomics (2011) 1.14
Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am J Clin Pathol (2006) 1.13
Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis (2003) 1.13
Mass spectrometry measurement of plasma hepcidin for the prediction of iron overload. Clin Chem Lab Med (2010) 1.11
Post-analytical errors with portable glucose meters in the hospital setting. Clin Chim Acta (2009) 1.11
One hundred years of laboratory testing and patient safety. Clin Chem Lab Med (2007) 1.10
A new sampling device for faecal immunochemical testing: haemoglobin stability is still an open issue. Clin Chem Lab Med (2014) 1.10
Harmonization of quality indicators in laboratory medicine. A preliminary consensus. Clin Chem Lab Med (2014) 1.09
Improving diagnosis and reducing diagnostic errors: the next frontier of laboratory medicine. Clin Chem Lab Med (2016) 1.09
Exploring the initial steps of the testing process: frequency and nature of pre-preanalytic errors. Clin Chem (2011) 1.09
Near-infrared spectroscopy as continuous real-time monitoring for kidney graft perfusion. Pediatr Nephrol (2013) 1.08